bpc-157 avis Dosing (Common Protocols) πΉ Oral / Subcutaneous β’ 500 mcg daily β’ Duration: 6 weeks πΉ Intramuscular / Peritendinous β’ 1 mg daily β’ Duration: 6 weeks β οΈ Note: Not approved BPC-157 | Research Peptide |
Description
Patients with musculoskeletal injury, systemic inflammation, or recovery goals outside the GI tract need injectable delivery for reliable systemic bioavailability

Lim E-J, Ahn Y-C, Jang E-S, Lee S-W, Lee S-H, Son C-G

You may have to take it once or twice a week depending on your condition your nutritional balance

Never inject the same spot on consecutive weeks
